Segment and Geographic Information

6 Months Ended

Jun. 30, 2013

Segment and Geographic Information

14.          Segment and Geographic Information

The Company has one reportable operating segment, the results of which are disclosed in the accompanying unaudited condensed consolidated financial statements.

Product revenue by product group is as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2013		2012		2013		2012
Orthobiologics	$	16,506,226	$	10,903,364	$	27,789,773	$	21,020,209
Dermal		557,059		155,735		798,643		657,051
Surgical		1,830,022		1,464,505		2,818,886		2,448,133
Ophthalmic		464,340		5,299,732		1,392,798		6,623,726
Veterinary		709,760		1,058,941		1,761,796		1,746,486
	$	20,067,407	$	18,882,277	$	34,561,896	$	32,495,605

Total revenue by geographic location and as a percentage of total revenue, for the three and six months ended June 30, 2013 and 2012 are as follows:

	Three Months Ended June 30,
	2013					2012
			Percentage of					Percentage of
	Revenue		Revenue			Revenue		Revenue
Geographic Location:
United States	$	15,482,068		74	%	$	16,728,331		85	%
Europe		1,986,195		10	%		1,128,126		6	%
Other		3,360,114		16	%		1,768,312		9	%
Total	$	20,828,377		100	%	$	19,624,769		100	%

	Six Months Ended June 30,
	2013					2012
			Percentage of					Percentage of
	Revenue		Revenue			Revenue		Revenue
Geographic Location:
United States	$	27,765,515		77	%	$	27,835,044		82	%
Europe		3,569,963		10	%		2,929,543		9	%
Other		4,739,910		13	%		3,220,842		9	%
Total	$	36,075,388		100	%	$	33,985,429		100	%